PVL

Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability

Retrieved on: 
목요일, 5월 9, 2024
Research, Surgery, Medical Devices, Health Technology, Cardiology, Biotechnology, Health, Pharmaceutical, Science, Society, University, Edwards Lifesciences, STS, Risk, TVT, Ultra, Freedom, Calcification, JACC: Cardiovascular Interventions, Patient, CRT, Failure, Quality of life, PVL, Cardiovascular disease, CE, Medical imaging

Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.

Key Points: 
  • Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.
  • “SAPIEN 3 Ultra RESILIA gives these patients a promising option, as RESILIA tissue’s calcium-blocking technology addresses structural valve deterioration, one of the primary causes of reintervention following heart valve replacement.”
    RESILIA tissue is already used in the world’s leading surgical aortic valve, the Edwards INSPIRIS RESILIA valve.
  • Today, the SAPIEN 3 Ultra RESILIA valve is the only transcatheter heart valve on the market with dry tissue storage.
  • A study of the SAPIEN 3 Ultra RESILIA valve found lower rates of paravalvular leak (PVL) at 30 days, lower echo-derived gradients and larger effective orifice areas across all valve sizes when compared to the SAPIEN 3 and SAPIEN 3 Ultra valves.

Permianville Royalty Trust Announces Filing of Annual Report on Form 10-K

Retrieved on: 
월요일, 3월 25, 2024
Oil, Gas, Energy, Bank, Bank statement, Annual report, PVL

Permianville Royalty Trust (NYSE: PVL) (the “Trust”) today announced that its Annual Report on Form 10-K for the year ended December 31, 2023 was with the SEC on March 22, 2024.

Key Points: 
  • Permianville Royalty Trust (NYSE: PVL) (the “Trust”) today announced that its Annual Report on Form 10-K for the year ended December 31, 2023 was with the SEC on March 22, 2024.
  • The Annual Report on Form 10-K is available in the “SEC Filings” section of the Trust’s website at www.permianvilleroyaltytrust.com , as well as on the SEC’s website at www.sec.gov .
  • Trust unitholders have the ability to request a printed copy of the Annual Report on Form 10-K, which contains the Trust’s audited financial statements, free of charge (via first class mail) by sending a written request to Permianville Royalty Trust, The Bank of New York Mellon Trust Company, N.A., 601 Travis Street, 16th Floor, Houston, TX 77002.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20240325670844/en/

Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR

Retrieved on: 
월요일, 3월 11, 2024
Health, Medical Devices, Surgery, Clinical Trials, Research, Science, Cardiology, Registry, CRT, Aortic stenosis, TVT, Patient, Journal, Stroke, Mortality, Ultra, Oakland University, MD, Cardiovascular disease, American College, TAVR, Arrest, JACC, PVL, Medical imaging

Edwards Lifesciences (NYSE: EW) announced today at Cardiovascular Research Technologies (CRT) 2024 the compelling results from two large, real-world studies based on TVT Registry data that demonstrated continued excellent outcomes for patients treated with the Edwards SAPIEN valve platform.

Key Points: 
  • Edwards Lifesciences (NYSE: EW) announced today at Cardiovascular Research Technologies (CRT) 2024 the compelling results from two large, real-world studies based on TVT Registry data that demonstrated continued excellent outcomes for patients treated with the Edwards SAPIEN valve platform.
  • In a second study presented during the late-breaking clinical trials session, small Edwards SAPIEN TAVR valves demonstrated equally excellent outcomes at 3 years as compared to larger SAPIEN TAVR valve sizes.
  • The study found that all Edwards TAVR platforms demonstrated excellent PVL results.
  • An analysis of 8,100 propensity matched patients across more than 800 sites in the United States found that patients treated with a 20mm Edwards SAPIEN valve demonstrated excellent all-cause mortality and stroke outcomes at 3-years, equivalent to those receiving 23, 26 and 29mm SAPIEN valve sizes.

Anumá Aerospace Receives Matching Grant Award for Innovative Research and Development for Their Lighter-than-Air, Partial-Vacuum Lift Airship Technology

Retrieved on: 
목요일, 2월 8, 2024
Transfer, The One, Small Business Innovation Research, Hydrogen, NOAA, Helium, Growth, WIP, Safety, Ship, STTR, PVL, SBIR, Commerce, Aviation, Research, Entrepreneurship, Airline

"We're witnessing the renaissance of airships, but the industry needs a sustainable, affordable alternative to helium," said Diana Little, Co-Founder and CEO of Anumá Aerospace.

Key Points: 
  • "We're witnessing the renaissance of airships, but the industry needs a sustainable, affordable alternative to helium," said Diana Little, Co-Founder and CEO of Anumá Aerospace.
  • Designed to produce and control the aerostatic lift of lighter-than-air aircraft, Anumá Aerospace's technology is the first of its kind to create lift using partial vacuum.
  • Anumá Aerospace recently announced an SBIR Grant given by the National Oceanic and Atmospheric Administration (NOAA).
  • Anumá's technology could substantially reduce our operation costs, and reducing the need for helium or hydrogen will make our operations easier."

Children's Miracle Network Hospitals® Announces 11 New National Champions Advocating for Pediatric Healthcare

Retrieved on: 
화요일, 1월 2, 2024
Long, PVL, Walking, Nyla, Children's Specialized Hospital, Family, Hospital, Children's Hospital, Occupational therapy, Arrhythmia, Research, State, PTLS, Hope, Bed rest, NICU, Health, Organic, Eye, Infant, Nationwide Children's Hospital, Cancer, Cerebral palsy, Syndrome, Love, Fertilisation, Doctor of Philosophy, Long QT syndrome, Genetic testing, Children's Miracle Network Hospitals, Safety, Prediabetes, DSM-IV codes, National championship, Life, Health insurance

SALT LAKE CITY, Jan. 2, 2024 /PRNewswire-PRWeb/ -- Children's Miracle Network Hospitals proudly introduces its newest cohort of National Champions, a group of extraordinary ambassadors dedicated to raising awareness about the critical need for charitable donations to support pediatric healthcare. These inspirational children and their families hail from diverse backgrounds and represent various member hospitals across the U.S. Each Champion's unique journey exemplifies the profound impact of donations on their lives, underscoring the urgent need to support Children's Miracle Network Hospitals.

Key Points: 
  • Adeline - Duke Children's Hospital (Age: 8)
    "The stories of our National Champions emphasize the transformative impact of charitable donations on pediatric healthcare," said Aimee Daily, Ph.D., President & CEO, Children's Miracle Network Hospitals.
  • Children's Miracle Network Hospitals, the largest fundraising network for children's hospitals in the U.S. and Canada, partners with leading pediatric healthcare providers to give kids a world of possibilities.
  • "The stories of our National Champions emphasize the transformative impact of charitable donations on pediatric healthcare," said Aimee Daily, Ph.D., President & CEO, Children's Miracle Network Hospitals.
  • National Champions are a group of ambassadors for Children's Miracle Network Hospitals located throughout the U.S. As National Champions, they're key to informing the public that children's hospitals are charities in need of donations.

Xenter Unveils Groundbreaking Investigational Dual Sensor Wireless GuideWire for Minimally Invasive TAVR Procedures at TCT 2023

Retrieved on: 
수요일, 11월 8, 2023
Cardiology, Data Management, Medical Supplies, Technology, Professional Services, Health, General Health, Venture Capital, Software, Artificial Intelligence, Mobile, Wireless, Aortic regurgitation, Cardiac catheterization, Physician, Para, Data collection, Multimedia, Artificial intelligence, Aortic stenosis, TAVR, Columbia, PVL, Physical, TCT, Collection, AR, Hospital, Medical imaging, Medical device, Medicine

Xenter, Inc. ( Xenter.io ) announced the recent unveiling of its groundbreaking dual sensor investigational guidewire for TAVR procedures at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference in San Francisco, CA.

Key Points: 
  • Xenter, Inc. ( Xenter.io ) announced the recent unveiling of its groundbreaking dual sensor investigational guidewire for TAVR procedures at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference in San Francisco, CA.
  • The guidewire is designed to operate seamlessly within a proprietary wireless ecosystem in the Cardiac Catheterization Lab making real-time data and analysis more accessible than ever.
  • Rich Linder, Chairman/CEO of Xenter, founded Xenter to revolutionize the collection of Physical Intelligence™ (PI) data into actionable insights.
  • “We built Xenter to enable Artificial Intelligence (AI) tools to be utilized with ease and accuracy using new smart/wireless medical devices that transmit real-time PI data .

Permianville Royalty Trust Announces Monthly Cash Distribution

Retrieved on: 
월요일, 10월 16, 2023
Energy, Professional Services, Oil, Gas, Finance, NYSE, Natural gas, PVL, Cryptocurrency, Life insurance

Permianville Royalty Trust (NYSE: PVL, the “Trust”) today announced a cash distribution to the holders of its units of beneficial interest of $0.006000 per unit, payable on November 13, 2023 to unitholders of record on October 31, 2023.

Key Points: 
  • Permianville Royalty Trust (NYSE: PVL, the “Trust”) today announced a cash distribution to the holders of its units of beneficial interest of $0.006000 per unit, payable on November 13, 2023 to unitholders of record on October 31, 2023.
  • The net profits interest calculation represents reported oil production for the month of July 2023 and reported natural gas production during June 2023.
  • The calculation includes accrued costs incurred in August 2023.
  • The following table displays reported underlying oil and natural gas sales volumes and average received wellhead prices attributable to the current and prior month recorded net profits interest calculations.

Cignal TV taps Quickplay platform for Pilipinas Live global sports app

Retrieved on: 
화요일, 9월 26, 2023
Sport, UAAP, Philippine Basketball Association, Entertainment Studios, PLDT, OTT, PVL, Filipinos, Cignal TV, PBA, API, Entertainment, Video game, QuickPlay

Pilipinas Live highlights Cignal TV's premier sports properties for the global audience, including the UAAP, which kicks off its new season starting with men's basketball on September 30, 2023.

Key Points: 
  • Pilipinas Live highlights Cignal TV's premier sports properties for the global audience, including the UAAP, which kicks off its new season starting with men's basketball on September 30, 2023.
  • Using the Quickplay platform, the network provides high-quality, live and on-demand coverage of events to Pinoy sports fans throughout the Philippines, as well as to the millions of Filipinos around the world.
  • "Sports is a unifying force for Filipinos, no matter where they may be," said Jane Basas, President of Cignal TV.
  • "When Cignal TV embarked on the development of Pilipinas Live, they wanted a world class experience that would reflect the prestige of the sporting events it would carry," said Goutham Vinjamuri, COO and Co-Founder of Quickplay.

Permianville Royalty Trust Announces Closing of Permian Basin Divestiture

Retrieved on: 
수요일, 8월 9, 2023
Energy, Professional Services, Oil, Gas, Finance, Permian, Sponsor, Bank, NYSE, PVL, Sale, Security (finance), Life insurance, Real estate, Trust

Permianville Royalty Trust (NYSE: PVL, the “Trust”) today announced that COERT Holdings 1, LLC (the “Sponsor”) has advised The Bank of New York Mellon Trust Company, N.A., as Trustee, that the Sponsor has completed the divestiture of certain oil and natural gas properties in the Permian Basin (the “Divestiture Properties”) that constitute part of the properties burdened by the Trust’s 80% net profits interest.

Key Points: 
  • Permianville Royalty Trust (NYSE: PVL, the “Trust”) today announced that COERT Holdings 1, LLC (the “Sponsor”) has advised The Bank of New York Mellon Trust Company, N.A., as Trustee, that the Sponsor has completed the divestiture of certain oil and natural gas properties in the Permian Basin (the “Divestiture Properties”) that constitute part of the properties burdened by the Trust’s 80% net profits interest.
  • As previously announced, at a special meeting of the Trust unitholders on July 19, 2023, the Trust unitholders approved a transaction pursuant to which (i) the Sponsor would sell the Divestiture Properties, (ii) the Trust would release the related net profits interest associated with the Divestiture Properties, and (iii) the net proceeds received by the Trust with respect to such sale would be distributed to the unitholders.
  • The total proceeds received by the Sponsor from the Divestiture Properties, after preliminary closing adjustments, were approximately $6.5 million, inclusive of the escrow funded by the buyer and partial expense reimbursement associated with the proxy solicitation.
  • Within 12 months after the closing of the sale, any remaining amount held in the indemnification escrow will be released to the Trust and included in a distribution to unitholders.

Permianville Royalty Trust Unitholders Approve Proposal For Sponsor To Sell Properties In The Permian Basin

Retrieved on: 
월요일, 7월 24, 2023
Energy, Professional Services, Oil, Gas, Finance, Permian, Conveyance, Net, NYSE, Sponsor, PVL, Sale, Security (finance), Trust

Permianville Royalty Trust (NYSE: PVL, the “Trust”) today announced that at the special meeting of Trust unitholders held on July 19, 2023, unitholders approved a transaction pursuant to which (a) COERT Holdings I, LLC (the “Sponsor”), the sponsor of the Trust, will sell certain oil and natural gas properties in the Permian Basin (the “Divestiture Properties”) that constitute a portion of the properties burdened by the Trust’s 80% net profits interest, (b) the Trust will release the related net profits interest associated with the Divestiture Properties and (c) the net proceeds received by the Trust with respect to such sale will be distributed to the unitholders.

Key Points: 
  • Permianville Royalty Trust (NYSE: PVL, the “Trust”) today announced that at the special meeting of Trust unitholders held on July 19, 2023, unitholders approved a transaction pursuant to which (a) COERT Holdings I, LLC (the “Sponsor”), the sponsor of the Trust, will sell certain oil and natural gas properties in the Permian Basin (the “Divestiture Properties”) that constitute a portion of the properties burdened by the Trust’s 80% net profits interest, (b) the Trust will release the related net profits interest associated with the Divestiture Properties and (c) the net proceeds received by the Trust with respect to such sale will be distributed to the unitholders.
  • The vote in favor of the sale of the Divestiture Properties constituted more than the required 50% of the Trust units outstanding as of the record date for the special meeting and, as a result, the proposal was approved by the Trust unitholders.
  • Closing of the sale of the Divestiture Properties is expected to occur before August 31, 2023.
  • Following the closing, the Sponsor will set a record date for the special distribution and within 45 days after the closing of the transaction, the Sponsor will distribute 80% of the net proceeds of the sale, less 80% of the expenses associated with the transaction and proxy meeting expenses and associated holdback amount, to unitholders of record.